Peter Kellman Selected Research

Gadolinium

1/2022	Detailed Assessment of Low-Voltage Zones Localization by Cardiac MRI in Patients With Implantable Devices.
11/2021	Bright-blood and dark-blood phase sensitive inversion recovery late gadolinium enhancement and T1 and T2 maps in a single free-breathing scan: an all-in-one approach.
1/2021	Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
1/2021	Myocardial Perfusion Imaging After Severe COVID-19 Infection Demonstrates Regional Ischemia Rather Than Global Blood Flow Reduction.
1/2020	Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
1/2020	Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
11/2019	Detection of myocarditis using T1 and ECV mapping is not improved by early compared to late post-contrast imaging.
3/2019	Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.
1/2019	Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
1/2018	Detection of Recent Myocardial Infarction Using Native T1 Mapping in a Swine Model: A Validation Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Kellman Research Topics

Disease

16	Myocardial Infarction 01/2020 - 02/2002
13	Fibrosis (Cirrhosis) 01/2020 - 11/2010
11	Infarction (Infarctions) 01/2021 - 06/2004
8	Amyloidosis 04/2021 - 10/2015
6	Cicatrix (Scar) 01/2022 - 11/2017
6	Cardiomyopathies (Cardiomyopathy) 01/2021 - 05/2012
5	Heart Failure 12/2021 - 11/2013
5	Edema (Dropsy) 10/2017 - 05/2011
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 09/2013
4	Ischemia 01/2021 - 11/2012
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 12/2014
3	Immunoglobulin Light-chain Amyloidosis 01/2020 - 10/2015
3	Fabry Disease (Fabry's Disease) 01/2019 - 12/2014
3	ST Elevation Myocardial Infarction 08/2017 - 05/2011
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2021
2	Iron Overload 01/2022 - 10/2017
2	Thalassemia 01/2022 - 08/2016
2	Infections 11/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Myocarditis (Carditis) 01/2021 - 11/2019
2	Cardiotoxicity 11/2017 - 01/2017
2	Hyperemia 02/2017 - 02/2012
2	Heart Diseases (Heart Disease) 10/2016 - 09/2012
2	Atherosclerosis 01/2014 - 09/2012
1	Hereditary Spherocytosis 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Left Ventricular Dysfunction 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Convalescence 01/2021
1	Hypertrophy 01/2020
1	Stroke (Strokes) 01/2020
1	Stable Angina 10/2019
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 05/2017
1	Ventricular Tachycardia 05/2017
1	Necrosis 02/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Ventricular Remodeling 10/2016
1	Hemorrhage 10/2016
1	Tics (Tic) 08/2016
1	Sinus Arrhythmia 06/2016
1	Congenital Heart Defects (Congenital Heart Defect) 06/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 09/2012
1	Death (Near-Death Experience) 09/2012
1	Obesity 08/2012
1	Pediatric Obesity 08/2012
1	Coronary Occlusion 09/2010
1	Hypoxia (Hypoxemia) 04/2010

Drug/Important Bio-Agent (IBA)

39	GadoliniumIBA 01/2022 - 02/2002
7	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2012
4	Amyloid (Amyloid Fibrils)IBA 04/2021 - 10/2015
4	Prealbumin (Transthyretin)IBA 01/2021 - 10/2015
4	Vasodilator Agents (Vasodilators)IBA 01/2019 - 11/2012
3	IronIBA 01/2022 - 08/2016
3	TroponinIBA 01/2021 - 01/2016
3	triphenyltetrazoliumIBA 01/2017 - 03/2006
2	MetalsIBA 03/2019 - 11/2017
2	SphingolipidsIBA 01/2019 - 12/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 01/2018
2	CobaltIBA 11/2017 - 01/2016
2	CollagenIBA 10/2017 - 01/2017
2	Contrast MediaIBA 01/2014 - 10/2013
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2014 - 09/2013
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	empagliflozinIBA 12/2021
1	Sodium-Glucose Transport ProteinsIBA 12/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	patisiranIBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	PlasticsIBA 01/2018
1	Troponin T (Troponin T1)IBA 01/2018
1	IonsIBA 11/2017
1	GlycosphingolipidsIBA 10/2017
1	Amyloidogenic ProteinsIBA 10/2017
1	C.I. direct red 80IBA 08/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2017
1	gadobutrolIBA 02/2017
1	AnthracyclinesIBA 01/2017
1	ChromiumIBA 01/2016
1	regadenoson FDA Link 09/2013
1	CalciumIBA 09/2012
1	N 30IBA 05/2012

Therapy/Procedure

4	Percutaneous Coronary Intervention 08/2017 - 09/2010
3	Microspheres (Microsphere) 01/2017 - 09/2010
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2021
2	Therapeutics 05/2017 - 10/2016
1	Heart Transplantation (Grafting, Heart) 08/2017
1	Transplantation 08/2017
1	Radiofrequency Ablation 05/2017
1	Catheter Ablation 05/2017
1	Hip Prosthesis 01/2016
1	Heart-Assist Devices 09/2012
1	Ligation 11/2010